Shelter Pharma Limited has submitted a regulatory filing to BSE Limited pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company will hold a Board of Directors meeting on Saturday, 07th November, 2026 at its corporate office located at 5th Floor, 501 SAKAR 4, Opp. Town Hall, Ashram Road, Ahmedabad, Gujarat - 380006.
The primary agenda for the meeting is to consider, approve, and take on record the Un-audited Financial Results for the half year ended on September 30, 2026, in compliance with Regulation 33 of SEBI LODR Regulations, 2015. The board will also review the Limited Review Report on these financial results.
The meeting may include other agendas that may be considered necessary with the permission of the chair.
The company has extended its trading window closure period, which was previously communicated in connection with this board meeting. The trading window will now remain closed until 48 hours after the declaration/publication of the financial results, specifically until Monday, November 09, 2026.
This board meeting intimation will be made available on the company's website at https://shelter.co.in.